UBS lowered the firm’s price target on Canada Goose (GOOS) to $12 from $14 and keeps a Neutral rating on the shares. Canada Goose’s Q3 results, the seasonal peak, indicated that the turnaround has yet to translate into the expected financial improvement, the analyst tells investors in a research note. With no clear near-term catalysts, sentiment is unlikely to change meaningfully until evidence of earnings impact potentially emerges in 3Q27, UBS says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOOS:
- Canada Goose price target lowered to C$12 from C$14 at Williams Trading
- Canada Goose downgraded to Neutral from Outperform at Baird
- Canada Goose downgraded to Underweight from Equal Weight at Barclays
- Canada Goose Stock (GOOS) Crashes 20% After Big Earnings Miss
- Canada Goose Posts Higher Revenue but Swings to Year-to-Date Loss in Q3 2025 Filing
